Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Elena Tóthová"'
Autor:
Hana Klamová, Kateřina Machová Poláková, Jan Mužík, Zdeněk Ráčil, Daniela Žáčková, Kateřina Steinerová, Michal Karas, Edgar Faber, Eva Demečková, Zuzana Michalovičová‐Sninská, Jaroslava Voglová, Ľudmila Demitrovičová, Eva Mikušková, Elena Tóthová, Juraj Chudej, Imrich Markuljak, Eduard Cmunt, Jana Moravcová, Dana Dvořáková, Kyra Michalová, Marie Jarošová, Markéta Marková Šťastná, Petr Cetkovský, Ladislav DuŠek, Vladimír Koza, Marek Trněný, Karel Indrák
Publikováno v:
Cancer Medicine, Vol 2, Iss 2, Pp 216-225 (2013)
Abstract We evaluated responses to the treatment and long‐term outcomes of chronic myeloid leukemia patients treated with imatinib as first‐line treatment in routine clinical setting from two countries with centralized tyrosine kinase inhibitors
Externí odkaz:
https://doaj.org/article/3352c3f69ea544aab068556ac3c96068
Autor:
Heinz Ludwig, Zdenek Adam, Elena Tóthová, Roman Hajek, Boris Labar, Miklós Egyed, Ivan Spicka, Heinz Gisslinger, Johannes Drach, Ingrid Kuhn, Axel Hinke, Niklas Zojer
Publikováno v:
Haematologica, Vol 95, Iss 9 (2010)
Background Thalidomide maintenance therapy after stem cell transplantation resulted in increased progression-free survival and overall survival in a few trials, but its role in non-transplant eligible patients with multiple myeloma remains unclear. T
Externí odkaz:
https://doaj.org/article/d718393f6f4247b18c2d97177c6bf9da
Publikováno v:
Leukemia & Lymphoma. 58:1726-1729
Chronic lymphocytic leukemia (CLL) is a neoplastic disorder characterized by the clonal expansion of malignant B cells which accumulate in the bone marrow and peripheral blood. CLL B cells are stro...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3cea41ae72b435f74bd2ad9b98dc387c
https://doi.org/10.1080/10428194.2016.1251593
https://doi.org/10.1080/10428194.2016.1251593
Autor:
Daniela Zackova, Jaroslava Voglová, Katerina Machova Polakova, Karel Indrak, Jiri Mayer, Edgar Faber, Ludmila Demitrovicova, Jan Muzik, Imrich Markuljak, Juraj Chudej, Eduard Cmunt, Ladislav Dušek, Hana Klamova, Elena Tóthová, Zdenek Racil, Michal Karas, Tomas Kozak, Marie Jarošová, Eva Janoušová, Tomáš Pavlík, Eva Demečková
Publikováno v:
American Journal of Hematology. 88:790-797
Using the data of 723 chronic myeloid leukemia (CML) patients in the chronic phase, we analyzed the prognostic value of the Sokal, Euro, and EUTOS scores as well as the level of BCR-ABL1 and the achievement of complete cytogenetic response (CCgR) at
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::946fa9ab3eb4fdbedd38455aed2dfdaa
https://doi.org/10.1002/ajh.23508
https://doi.org/10.1002/ajh.23508
Autor:
Marek Trněný, Michal Karas, Imrich Markuljak, Kateřina Machová Poláková, Jaroslava Voglová, Karel Indrak, Jan Mužík, Kyra Michalova, Marie Jarošová, Markéta Marková Šťastná, Vladimir Koza, Zdeněk Ráčil, Kateřina Steinerová, Elena Tóthová, Ľudmila Demitrovičová, Eva Mikuskova, Eva Demečková, Eduard Cmunt, Edgar Faber, Daniela Žáčková, Ladislav Dušek, Dana Dvořáková, Zuzana Michalovičová-Sninská, Hana Klamova, Juraj Chudej, Petr Cetkovský, Jana Moravcová
Publikováno v:
Cancer Medicine. 2:216-225
We evaluated responses to the treatment and long-term outcomes of chronic myeloid leukemia patients treated with imatinib as first-line treatment in routine clinical setting from two countries with centralized tyrosine kinase inhibitors (TKIs) treatm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1de8c83512329e9d750d3b06a947baec
https://doi.org/10.1002/cam4.59
https://doi.org/10.1002/cam4.59
Autor:
Nad'a Mallátová, Michal Kouba, Jan Haber, Zdenek Racil, Peter Múdry, Eva Bojtárová, Lubos Drgona, Renata Foralová, Elena Tóthová, Lucia Masárová, Barbora Weinbergerova, Jan Muzik, Barbora Ziakova, Jan Vydra, Tomáš Guman, Jiri Mayer, Daniela Sejnová, Iva Kocmanová, Petr Cetkovsky, Kristina Forsterova, Vít Kandrnal
Publikováno v:
International Journal of Infectious Diseases. 17(2):e101-e109
Summary Objectives To evaluate risk factors, diagnostic procedures, and treatment outcomes of invasive aspergillosis (IA) in patients with hematological malignancies. Methods A retrospective analysis of data from proven/probable IA cases that occurre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d56ee0bf8e899c138af04c3f558e8c01
Autor:
Eduard Cmunt, Ludmila Demitrovicova, Jaroslava Voglová, Imrich Markuljak, Juraj Chudej, Tomas Kozak, Edgar Faber, Marie Jarošová, Karel Indrak, Vladimir Koza, Elena Tóthová, Ladislav Dušek, Eva Demečková, Jan Mužík
Publikováno v:
European Journal of Haematology. 87:157-168
Most results on the treatment of chronic myeloid leukaemia (CML) with imatinib were obtained from clinical trials that may differ from the routine practice. We report the results of treatment of consecutive patients with CML at ten major centres duri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::536a4039579cc04e005b806d36c6fa0f
https://doi.org/10.1111/j.1600-0609.2011.01637.x
https://doi.org/10.1111/j.1600-0609.2011.01637.x
Autor:
Ludmila Demitrovicova, Jana Lesko-Andrascikova, Adriana Kafková, Zuzana Sninská, Eva Mikuskova, Martin Mistrik, Tereza Nečasová, Stanislav Palasthy, Katarina Slezakova, Juraj Chudej, Eva Koritakova, Imrich Markuljak, Natalia Stecova, Elena Tóthová
Publikováno v:
ResearcherID
Introduction: With the onset of tyrosine kinase inhibitors (TKI) to treat patients with CML, the number of patients and overall survival increased and quality of life significantly improved. The basic principle of therapy was also changed, according
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb741c467c20df0c93539a7c8f0a9f06
https://doi.org/10.1182/blood.v128.22.3087.3087
https://doi.org/10.1182/blood.v128.22.3087.3087
Autor:
Hana, Klamová, Kateřina Machová, Poláková, Jan, Mužík, Zdeněk, Ráčil, Daniela, Záčková, Kateřina, Steinerová, Michal, Karas, Edgar, Faber, Eva, Demečková, Zuzana, Michalovičová-Sninská, Jaroslava, Voglová, Ludmila, Demitrovičová, Eva, Mikušková, Elena, Tóthová, Juraj, Chudej, Imrich, Markuljak, Eduard, Cmunt, Jana, Moravcová, Dana, Dvořáková, Kyra, Michalová, Marie, Jarošová, Markéta Marková, Sťastná, Petr, Cetkovský, Ladislav, Dušek, Vladimír, Koza, Marek, Trněný, Karel, Indrák
Publikováno v:
Cancer Medicine
We evaluated responses to the treatment and long-term outcomes of chronic myeloid leukemia patients treated with imatinib as first-line treatment in routine clinical setting from two countries with centralized tyrosine kinase inhibitors (TKIs) treatm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a17aaf042eaf8e03b90ec1cd1ec6af58
https://pubmed.ncbi.nlm.nih.gov/23634289
https://pubmed.ncbi.nlm.nih.gov/23634289
Autor:
Jiri Mayer, Martina Tošková, Barbora Ziakova, Zdenek Racil, Kristina Forsterova, Julia Gabzdilova, Monika Rolencová, Lucia Masárová, Iva Kocmanová, Jan Haber, Petr Cetkovsky, Tomáš Guman, Eva Bojtárová, Lucie Burešová, Shira Timilsina, Michal Kouba, Elena Tóthová, Lubos Drgona
Publikováno v:
Leukemialymphoma. 54(5)
The objective of this retrospective, multicenter study was to evaluate the efficacy and safety of micafungin as empirical antifungal therapy during febrile neutropenia (FN) in 73 hematological patients from six centers in two countries. All patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::275eb133daf6250d09c877ec3d9f3dbd
https://pubmed.ncbi.nlm.nih.gov/23088794
https://pubmed.ncbi.nlm.nih.gov/23088794